BRAF V600R
|
Melanoma
|
BRAF V600R
|
Melanoma
|
vemurafenib Sensitive: C3 – Early Trials
|
vemurafenib Sensitive: C3 – Early Trials
|
BRAF V600R
|
Melanoma
|
BRAF V600R
|
Melanoma
|
dabrafenib Sensitive: C3 – Early Trials
|
dabrafenib Sensitive: C3 – Early Trials
|
BRAF V600R
|
Melanoma
|
BRAF V600R
|
Melanoma
|
trametinib Sensitive: C3 – Early Trials
|
trametinib Sensitive: C3 – Early Trials
|